Skip to main content

A U.S. bankruptcy judge on Thursday urged parties that will benefit from a proposed settlement with OxyContin maker Purdue Pharma LP to focus on addressing the opioid addiction crisis and avoid battling over the deal’s billions of dollars.

The outline of a proposed settlement that Purdue values at more than US$10-billion was filed in the U.S. Bankruptcy Court in White Plains, New York on Tuesday.

The deal aims to resolve more than 2,600 lawsuits by states, local governments and other plaintiffs against Purdue and its Sackler family owners. The lawsuits accuse them of fueling a public health crisis by aggressively marketing opioids while downplaying their overdose risks, contributing to 400,000 deaths since 1999, according to U.S. statistics.

Story continues below advertisement

“No one can ignore the individual people affected by this crisis,” said U.S. Bankruptcy Judge Robert Drain at a Thursday hearing. “So I hope that you all will be able to work together to use the money as wisely as possible.”

Drain urged the parties to consider ways to distribute settlement funds quickly, rather than follow the usual pattern of a Chapter 11 bankruptcy, which involves evaluating each creditor claim before making payments.

He mentioned as examples the litigation settlements involving victims of Vietnam War herbicide Agent Orange, the Sept. 11, 2001 attacks and the BP Plc oil spill. Those cases were resolved using compensation funds established to settle large numbers of lawsuits for personal injury and other claims.

The opioid litigation has been compared to the cases by states against tobacco companies that led to a $246 billion settlement in 1998. States have been criticized for redirecting some of the money toward budget shortfalls and other uses unrelated to preventing smoking or treating those who suffered from related illnesses.

Drain also said bankruptcy law could be used to bind permanently how the Purdue settlement funds were used.

Thursday’s hearing was scheduled to consider Purdue’s request to pay more than $30 million in bonus payments and severance for Purdue employees. The most controversial parts of that request were rescheduled for Nov. 6.

On Friday, Drain will consider a request by Purdue to pause all litigation against the company and the Sacklers, which has been opposed by 25 states.

Story continues below advertisement

Purdue said it needs to pause the litigation to preserve its cash and to try to settle with the hold-out plaintiffs.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter